Michael Fryar
Family · Cleveland, TNNPI 1578229373
Payments from drug & device makers
Across 143 payments — averaging $23.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$678
- Bayer$433
- Mallinckrodt Hospital Products Inc.$278
- Vifor Pharma, Inc.$276
- Amgen$270
- Travere Therapeutics, Inc.$176
- plus $1K from 18 others
What the payments were for
- Food & beverage$3,17896%
- Education$1314%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 23 | $678 |
| Bayer | 17 | $433 |
| Mallinckrodt Hospital Products Inc. | 13 | $278 |
| Vifor Pharma, Inc. | 13 | $276 |
| Amgen(2 entities) | 16 | $270 |
| Travere Therapeutics, Inc. | 10 | $176 |
| Novartis | 5 | $165 |
| Otsuka America Pharmaceutical, Inc. | 8 | $162 |
| Bard Peripheral Vascular, Inc. | 1 | $135 |
| OPKO Pharmaceuticals, LLC | 7 | $118 |
| Ardelyx, Inc. | 4 | $90 |
| Novo Nordisk | 4 | $82 |
| Nxstage Medical, Inc. | 1 | $72 |
| Calliditas Therapeutics US Inc. | 4 | $71 |
| Boehringer Ingelheim | 4 | $64 |
| Shield Therapeutics Inc | 3 | $61 |
| Fresenius USA Marketing, Inc. | 2 | $40 |
| Renalytix AI, Inc. | 2 | $36 |
| Kyowa Kirin, Inc. | 1 | $22 |
| Scpharmaceuticals Inc. | 1 | $18 |
| Aurinia Pharma U.S., Inc. | 1 | $18 |
| Apellis Pharmaceuticals, Inc. | 1 | $16 |
| GSK | 1 | $15 |
| Akebia Therapeutics Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,309 in reported general payments places this provider in the 85th percentile of 6,706 family providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VeltassaPatiromer Calcium Sorbitex | 46 | $44,510 |
| KerendiaFinerenone | 44 | $39,215 |
| FarxigaDapagliflozin Propanediol | 24 | $24,715 |
| JardianceEmpagliflozin | 19 | $20,998 |
| RayaldeeCalcifediol | 14 | $18,345 |
| LokelmaSodium Zirconium Cyclosilicate | 14 | $5,537 |
| Midodrine Hcl | 12 | $1,806 |
| Calcitriol | 94 | $1,574 |
| Potassium Chloride | 26 | $1,245 |
| Famotidine | 46 | $893 |
| Losartan Potassium | 75 | $823 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 34 | $719 |
| Lisinopril | 111 | $596 |
| Telmisartan | 15 | $513 |
| Omeprazole | 35 | $418 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| BayerKerendia | $433 | $39,21544 claims |
| AstraZenecaFarxiga, Lokelma | $678 | $30,25338 claims |
| Boehringer IngelheimJardiance | $64 | $20,99819 claims |
| OPKO Pharmaceuticals, LLCRayaldee | $118 | $18,34514 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 6,706 family providers in Tennessee.
Other family in Cleveland
- Jateum BlackburnCleveland$143K
- Jodi RoseCleveland$57K
- Stacy BrownMt Juliet$719K
- Dana WebberKnoxville$499K
- Brandy BiedermanHixson$448K
- Cynthia MillerMurfreesboro$384K
- Tamera ThoenerNashville$254K
- April SwonerHermitage$246K
- Jennifer WilliamsNashville$213K
- Chantil JeffreysGermantown$195K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.